Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MSCs with CD25 Antibody and Calcineurin Inhibitors for Steroid-resistant aGVHD
NCT02241018Phase 3Unknown
- Sponsor
- Nanfang Hospital, Southern Medical University
- Start
- Sep 2014
- Primary completion
- Sep 2018
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 3 trial of mesenchymal stem cells in Acute Graft-Versus-Host Disease (aGvHD), sponsored by Nanfang Hospital, Southern Medical University. Status: unknown.
02
Drugs
mesenchymal stem cells
03
Conditions
Acute Graft-Versus-Host Disease (aGvHD)
Beyond the preview
Go deeper on NCT02241018.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02241018.